.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Baxter
UBS
Moodys
Cantor Fitzgerald
Queensland Health
Mallinckrodt
Accenture
Dow

Generated: September 21, 2017

DrugPatentWatch Database Preview

DOXYCHEL Drug Profile

« Back to Dashboard

What is the patent landscape for Doxychel, and what generic Doxychel alternatives are available?

Doxychel is a drug marketed by Rachelle and is included in two NDAs.

The generic ingredient in DOXYCHEL is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-one suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

Summary for Tradename: DOXYCHEL

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list31
Patent Applications: see list1,332
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXYCHEL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rachelle
DOXYCHEL
doxycycline
FOR SUSPENSION;ORAL061720-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Rachelle
DOXYCHEL HYCLATE
doxycycline hyclate
INJECTABLE;INJECTION061953-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Merck
QuintilesIMS
US Army
Johnson and Johnson
Baxter
Queensland Health
Boehringer Ingelheim
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot